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Chinese Geneticists Are Far from Eugenics Movement
To the Editor:
The article by Dr. Xin Mao (1998), published in the
September 1998 issue of the Journal, came to our at-
tention just recently. Unfortunately, it misrepresented in
many ways the real attitudes of many of the medical
geneticists in China. We feel that it is necessary to speak
out for ourselves. For instance, sickle cell anemia is as
rare among Chinese as it is among whites. The statement
that “sickle cell disease is very common in China” (Mao
1998, p. 690) is incorrect. Hence, there is no reason to
require newborn screening for sickle cell disease inChina
(Mao 1998, table 1). Cystic fibrosis is also very rare in
China. Hence, there is also no need to perform newborn
screening for this disease (Mao 1998, p. 690). Popula-
tion screening for defective alleles of the a-antitrypsin
gene (i.e., the PiZ and PiS alleles) has revealed none in
China, with the exception of one case with the genotype
of M1S. Therefore, it will be meaningless to conduct
genetic testing for a-antitrypsin deficiency among work-
ers in very dirty workplaces (Mao 1998, p. 689). Ac-
tually, it will be very difficult to define “very dirty work-
place.”Mao also stated that “almost all respondents said
that the goal of human genetics was ‘improvement of
the population quality, decrease of the population quan-
tity, and furtherance of eugenic principles’ and agreed
that ‘an important goal of genetic counseling is to reduce
the number of deleterious genes in the population’” (pp.
692–693). We wonder whether any knowledgeable hu-
man geneticists will believe that human genetics can de-
crease the population quantity. We also doubt that the
number of deleterious genes—especially “recessive
genes”—in the population can be readily reduced. As
for the term “eugenics,” one should be very careful not
to equate it with “you sheng” in Chinese, which means
“to give birth to a healthy baby.” There are many other
controversial points in Mao’s article. For example, his
table 4 asks whether the country should have laws to
prohibit disability discrimination. The original ques-
tionnaire, however, asked whether the country has or
does not have laws to prohibit disability discrimination.
The percentage given in table 4 will lead readers to the
conclusion that Chinese medical geneticists do not favor
the enactment of such laws! This letter will be too long
if we try to list all of the controversial points in Mao’s
article. We are fully aware that, because of differences
in culture, value systems, customs, religion, and demo-
graphic and economic situations, our viewpoints on
many ethical issues may be different than those of our
Western colleagues. This stresses the importance of di-
alogues between us to promote mutual understanding.
All constructive suggestions will be heartily welcome,
and we will be most grateful for all of them.
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Reply to Guo and to Chen et al.
To the Editor:
Ethical, legal, and social issues in human genetics are
hot—but also complicated—topics in developed coun-
tries. Since my article (Mao 1998a) about Chinese ge-
neticists’ views on ethical issues in genetic testing and
screening was published, it has attracted attention from
the international scientific community and the media.
Many gave positive comments on the article (Mao
1998b, 1998c; Coghlan 1998; Knoppers 1998), but oth-
ers, such as Guo (1999 [in this issue]) and Chen et al.
(1999 [in this issue]), expressed different views.
Ethical, legal, and social issues in human genetics are
very sensitive inside China (as well as elsewhere), and
there have been few Chinese scientists, either in genetics
or in the social sciences, willing to investigate these sub-
jects. For example, Chinese geneticists were invited to
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take part in the first international survey on ethics and
genetics, conducted in 1984, but none responded (Wertz
and Fletcher 1989). The report on ethics and genetics
in China presented in the September issue of the Journal
last year (Mao 1998a) came from the second interna-
tional survey on ethics and genetics, which was con-
ducted in 37 nations, including China, in 1993 (Wertz
and Fletcher 1993). In this survey, a total of 402 Chinese
geneticists, in 30 provinces and autonomous regions,
were targeted with the Chinese version of an anonymous
questionnaire that included 50 questions on ethical is-
sues. All of these geneticists were registered members of
the Chinese Association ofMedical Genetics, theHuman
and Medical Genetics Branch of the Chinese Society of
Genetics, and the Chinese Society of Family Planning.
In all, 255 (63%) Chinese geneticists responded. Al-
though some of the situations described in the ques-
tionnaire might be remote from Chinese geneticists’ own
practices in 1993, the survey results definitely helped to
define the geneticists’ attitudes toward ethical, legal, and
social issues in genetics at that time and provided, for
the first time, a scientific basis for international discus-
sion of ethical issues in genetics in China (Mao and
Wertz 1997; Wertz 1997, 1999; Mao 1998a; Wertz and
Fletcher 1998).
Eugenics and laws related to it are the most conten-
tious ethical issues in the world of genetics. On the basis
of the first comprehensive national survey data and the
actual situation in China, my article provided well-in-
formed evidence of the balanced opinions on eugenics
and genetics ethics in China, which aimed to promote
constructive dialogues between Chinese geneticists and
their Western counterparts on these issues. I agree with
Chen et al. (1999) in their desire for more-comprehen-
sive scientific reporting and more unbiased international
discussions on genetics ethics in China. Perhaps this is
the proper approach to exploring the cross-cultural eu-
genics and genetic ethics in developing nations.
Guo (1999) suggests that the article supports the “eu-
genics” section of China’s Maternal and Infant Health
Care Law. As I stated in the article, my purpose was to
present the survey data and to discuss the likely basis
of eugenics in China (Mao 1998a). Accomplishing this
aim does not mean I have to support or oppose the law.
The history of eugenics in Western society has shown
that socioeconomic and cultural factors contributed con-
siderably to the development of the movement in in-
dustrial nations (Paul 1992). Diko¨tter analyzed themany
dimensions of the history of eugenics in China. In his
book, Diko¨tter concluded that Chinese eugenics law re-
flects an articulation of Chinese knowledge of heredity
and disease and demonstrates how Chinese assumptions
about the relationship of the individual to the society
form the core of their attitudes toward procreation and
their cultural, social, and economic views of population
and disability, as well as the trend of nationalism gen-
erated from late imperial China to the People’s Republic
(Diko¨tter 1998). Diko¨tter’s studies provide evidence that
sociocultural differences are most likely to give rise to
a disagreement between China and the West on the eth-
ical, legal, and social issues that surround genetics, in-
cluding the issue of eugenics.
The aims of the International Survey on Ethics and
Genetics were to investigate the attitudes of genetics ser-
vice providers toward ethical, legal, and social issues in
their practice and research. The first section of the in-
ternational questionnaire collected the participants’ so-
ciodemographic data and made a particular effort to
check the credentials of the survey respondents. These
data have been presented elsewhere (Mao and Wertz
1997).
Guo (1999) suggests that better knowledge of genetics
will alter beliefs about reducing the number of delete-
rious genes in the population. China has made genetic
research the top priority of its basic science research
program and also has made a large-scale investment in
the Chinese HumanGenome Project (CHGP) (Lei 1998).
If Guo is correct, then Chinese beliefs about eugenics
will probably disappear in the future, when China
catches up to the West in genetics. Views have been
expressed in the West that, if genetic knowledge is not
used properly or ethically, then it is likely to do more
harm than good. My article (Mao 1998a) showed that,
in 1993, most Chinese geneticists thought that ethical
guidelines were necessary to improve genetics services in
China. So far, however, very few Chinese geneticists and
ethicists have been interested in the ethical, legal, and
social issues of CHGP, although enhancement of re-
search in this area has been listed as a subproject of
phase II of CHGP (Chen and Zhang 1998). Ethical
guidelines for genetics research and practice have not
been drafted, nor has there been any public debate on
these issues in China. All of these facts indicate that it
is imperative that the international genetics community
should export advanced genetics technologies to China
and should help the Chinese people learn how to use
genetic knowledge ethically to avoid any potential harm.
One approach to altering beliefs about eugenics depends
on facilitating public debate on these issues and estab-
lishing an evidence-based policy-making system world-
wide. Perhaps these will be the toughest issues in genetics
in the new millennium.
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The Duty to Recontact: Benefit and Harm
To The Editor:
The survey by Fitzpatrick et al. (1999), “The Duty to
Recontact: Attitudes of Genetics Services Providers,”
represents a significant contribution to, and an impor-
tant step forward in, the resolution of a complex and
troubling issue. But, in both their Introduction and their
Discussion, the authors refer to statements of mine
(Sharpe 1994b) that have been taken out of context and
therefore misrepresent my position on this issue. More
critically, Fitzpatrick et al. have failed to take note of
medical principles and legal obligations that are fun-
damental to discussion about whether a duty to recon-
tact exists within the context of medical genetics and
genetic counseling.
For example, the authors wrote that I stated “a phy-
sician’s duty of care toward patients is considered to
include the obligation to advise them of any develop-
ments in management and treatment that would be ben-
eficial or detrimental” (Sharpe 1994b). This statement,
in the context in which it is presented, is incorrect. My
article (Sharpe 1994b) focused on the psychological as-
pects of presymptomatic testing for Huntington disease
and, in particular, on whether a geneticist would have
a continuing obligation to provide psychological support
after disclosure of the test results. This issue was ex-
amined within the context of a physician’s traditional
postoperative duties of care to a patient, including the
duties to monitor a patient’s condition, to provide ap-
propriate aftercare, to refer, and not to abandon the
patient. As cited in my article, such obligations have long
been recognized in the various codes and principles of
ethics of organizations such as the American Medical
Association and the Canadian Medical Association.
With respect to Huntington disease, because of the
potential for and the nature of the psychological and
psychiatric responses associated with risk clarification
or a clinical diagnosis, I suggested that, in the sameman-
ner in which a physician may have a duty to continue
treatment until recovery is complete, a geneticist may
have a continuing duty of care until appropriate psy-
chological or psychiatric counseling has been arranged.
Once such counseling has been secured, however, the
geneticist’s obligation would come to an end.
In the same article, with respect to phenylketonuria,
I also speculated—as evidenced by my explicit use of the
term “theoretically”—that, because of the necessity of
maintaining a low-phenylalanine diet and the fact that
the gene technically has been expressed, a geneticist
might have a duty to monitor a patient’s condition over
